Share This Link

A maternal heart rate of 110 beats/min is a common, expected side effect of beta-adrenergic stimulation. While tachycardia is a known pharmacologic response, it typically does not require immediate cessation of therapy unless it exceeds 120 beats/min or causes hemodynamic instability.

Mild jitteriness and tremors are frequently reported adverse effects associated with the systemic activation of beta-adrenergic receptors. These symptoms are generally considered tolerable side effects of tocolytic therapy and do not represent an acute pathological crisis requiring immediate provider notification.

A maternal blood glucose level of 110 mg/dL is a common finding during terbutaline administration due to glycogenolysis. This mild hyperglycemic effect is a known metabolic consequence of the drug and is generally managed through routine monitoring rather than urgent clinical intervention.

Betamethasone is a glucocorticoid, not a tocolytic agent. It does not possess the pharmacological capacity to inhibit myometrial contractility or terminate preterm labor. Its administration is intended to improve neonatal outcomes rather than achieve uterine quiescence or cessation of labor.

Betamethasone is an immunosuppressive agent that may theoretically exacerbate an active infectious process. It is not an antibiotic or antimicrobial therapy and has no role in treating chorioamnionitis or other underlying pathogenic causes of preterm labor or premature rupture of membranes.

Betamethasone does not influence the coagulation cascade or uterine involution processes. It is not indicated for the prevention of postpartum hemorrhage, which is typically managed through uterotonics like oxytocin or mechanical interventions to ensure adequate hemostasis following the delivery of the placenta.

Deep tendon reflexes rated as 2+ bilaterally represent a normal physiological response on the standard neurological grading scale. This demonstrates adequate neuromuscular function and indicates that serum magnesium concentrations remain within a safe therapeutic range, negating the need for calcium gluconate administration or any pharmacological intervention.

A measured urine output of 50 mL/hr over the past hour exceeds the minimum physiological threshold of 30 mL/hr required for adequate renal clearance. Because magnesium is excreted primarily by the kidneys, this normal value ensures renal excretion and prevents drug accumulation or toxicity.

A serum magnesium level of 5 mEq/L falls well within the standard therapeutic target range of 4 to 7 mEq/L utilized during the management of preeclampsia. This concentration effectively prevents seizures without causing neurological depression or threatening cardiorespiratory stability.

Withholding antimicrobial therapy until definitive culture results return exposes the preterm fetus to unacceptable risks of ascending intrauterine infection. Clinical protocols dictate immediate intervention to suppress pathogens and prevent severe maternal chorioamnionitis.

Antifungal medications are entirely inappropriate as a primary therapeutic intervention because the clinical presentation indicates a high risk for bacterial infection rather than a fungal etiology. Standard protocols target typical organisms associated with membranes rupture complications.

Delaying antimicrobial administration until the onset of active labor fails to provide necessary prophylactic coverage during the critical latency period. Early intervention is vital for preventing neonatal bacteremia and subsequent multi-system morbidity.

Performing range-of-motion exercises while on bed rest is a correct clinical recommendation to maintain joint mobility and promote venous return, thereby mitigating the hazards of prolonged immobilization such as venous stasis and progressive musculoskeletal deconditioning during the management of preterm labor.

Reporting any calf pain or swelling immediately is a correct statement reflecting vigilant monitoring for deep vein thrombosis, a critical hypercoagulable complication associated with prolonged inactivity, elevated estrogen states, and altered hemodynamic parameters during advanced gestation.

Avoiding sexual intercourse as part of pelvic rest is a correct statement because seminal prostaglandins and mechanical cervical stimulation can trigger uterine contractions, making pelvic rest a standard non-pharmacological adjunct to tocolytic therapy in preventing cervical dilation.